Action 4105 TTY BIOPHARM COMPANY LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues TTY Biopharm Company Limited

Actions

4105

TW0004105002

Cours en clôture Taipei Exchange
Autres places de cotation
 00:00:00 10/05/2024 		Varia. 5j. Varia. 1 janv.
78,4 TWD +0,51% Graphique intraday de TTY Biopharm Company Limited +1,03% -2,49%
10/05 TTY Biopharm Company Limited annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI
14/03 TTY Biopharm Company Limited publie ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
TTY Biopharm Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024
TTY Biopharm Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
TTY Biopharm Company Limited Announces Change of CFO and Financial Officer
TTY Biopharm Company Limited Proposes Cash Dividend for the Year Ended December 31, 2023, Payable on April 26, 2024
TTY Biopharm Company Limited Appoints Peng,Cheng-Yi as Research and Development Officer, Effective February 01, 2024
TTY Biopharm Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
TTY Biopharm Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
TTY Biopharm Company Limited Receives Milestone Payment from German Pharmaceutical Company for Co-Development of Liposome Product-Pegylipo in Europe
TTY Biopharm Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
TTY Biopharm Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022
TTY Biopharm Company Limited Proposes Dividend Distribution for the Year Ended December 31, 2022, Payable on May 5, 2023
DelveInsight Estimates a Diverse Kaposi Sarcoma Pipeline Comprising 5+ Companies Working in the Domain
Aurobindo Pharma Arm Gets US FDA Nod for Amphotericin B Liposome
TTY Biopharm Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
TTY Biopharm Company Limited Announces Internal Audit Officer Changes, Effective November 7, 2022
TTY Biopharm : Announcement of TTY Biopharm's unaudited income information in July 2022
TTY Biopharm Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
TTY Biopharm : Announcement of the consolidated financial report for the second quarter of year 2022
TTY Biopharm : To clarify report of China Times, Commercial Times and Economic Daily News on Aug 02, 2022
TTY Biopharm : Announcement of TTY Biopharm's unaudited income information in June 2022
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 4105
  4. Actualités TTY Biopharm Company Limited
  5. Autres langues